Data Sharing for Demographic Research
A data archive for demography and population sciences

National Longitudinal Study of Adolescent Health (Add Health), 1994-2008: Wave IV Biomarker Data [Restricted Use] (ICPSR 33443) RSS

Principal Investigator(s):

Summary:

The National Longitudinal Study of Adolescent Health (Add Health) is a longitudinal study of a nationally representative sample of adolescents in grades 7-12 in the United States during the 1994-1995 school year. The Add Health cohort has been followed into young adulthood with four in-home interviews, the most recent in 2008, when the sample was aged 24-32. Add Health combines longitudinal survey data on respondents' social, economic, psychological, and physical well-being with contextual data on the family, neighborhood, community, school, friendships, peer groups, and romantic relationships, providing unique opportunities to study how social environments and behaviors in adolescence are linked to health and achievement outcomes in young adulthood. The fourth wave of interviews expanded the collection of biological data in Add Health to understand the social, behavioral, and biological linkages in health trajectories as the Add Health cohort ages through adulthood.

This component of the Add Health restricted data is the Biomarker Data. The Glucose/HbA1c data file contains two measures of glucose homeostasis based on assays of the Wave IV dried blood spots: Glucose (mg/dl) and Hemoglobin A1c (HbA1c, %). Six additional constructed measures -- fasting duration, classification of fasting glucose, classification of non-fasting glucose, classification of HbA1c, diabetes medication, and a joint classification of glucose, HbA1c, self-reported history of diabetes, and anti-diabetic medication use -- are also included.

The Lipids data file contains measures of triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol, and total cholesterol to high-density lipoprotein cholesterol ratio. Additional variables include, measurement method for triglycerides (TG), total cholesterol (TC), high-density lipoprotein choleserol (HDL-C), Antihyperlipidemic medication use, joint classification of self-reported history of Hyperlipidemia and Antihyperlipidemic medication use, and fasting duration.

For more information, please see the study website.

Access Notes

Study Description

Citation

Harris, Kathleen Mullan, and J. Richard Udry. National Longitudinal Study of Adolescent Health (Add Health), 1994-2008: Wave IV Biomarker Data [Restricted Use]. ICPSR33443-v5. Chapel Hill, NC: Carolina Population Center, University of North Carolina-Chapel Hill/Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributors], 2013-11-07. http://doi.org/10.3886/ICPSR33443.v5

Persistent URL:

Export Citation:

  • RIS (generic format for RefWorks, EndNote, etc.)
  • EndNote XML (EndNote X4.0.1 or higher)

Funding

This study was funded by:

  • United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
  • United States Department of Health and Human Services. National Institutes of Health. National Institute of Mental Health
  • United States Department of Health and Human Services. National Institutes of Health. National Institute of Nursing Research
  • United States Department of Health and Human Services. National Institutes of Health. Office of AIDS Research
  • United States Department of Health and Human Services. National Institutes of Health. Office of Behavioral and Social Sciences Research
  • United States Department of Health and Human Services. National Institutes of Health. Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01-HD31921)
  • United States Department of Health and Human Services. National Institutes of Health. National Cancer Institute
  • United States Department of Health and Human Services. National Institutes of Health. National Institute on Alcohol Abuse and Alcoholism
  • United States Department of Health and Human Services. National Institutes of Health. National Institute of General Medical Sciences
  • United States Department of Health and Human Services. National Institutes of Health. National Institute on Deafness and Other Communication Disorders
  • United States Department of Health and Human Services. Office of Public Health and Science. Office of Population Affairs
  • United States Department of Health and Human Services. National Institutes of Health. Office of Research on Women's Health
  • United States Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics
  • United States Department of Health and Human Services. Centers for Disease Control and Prevention. Office of Minority Health and Health Disparities
  • United States Department of Health and Human Services. Office of Public Health and Science. Office of Minority Health
  • United States Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation
  • National Science Foundation

Scope of Study

Methodology

Sample:   Wave I, Stage 1 School sample: stratified, random sample of all high schools in the United States. A school was eligible for the sample if it included an 11th grade and had a minimum enrollment of 30 students. A feeder school, a school that sent graduates to the high school and that included a 7th grade, was also recruited from the community. Wave I, Stage 2: An in-home sample of 27,000 adolescents was drawn consisting of a core sample from each community plus selected special over samples. Eligibility for over samples was determined by an adolescent's responses on the In-School Questionnaire. Adolescents could qualify for more than one sample. In addition, parents were asked to complete a questionnaire about family and relationships. The Wave II in-home interview sample is the same as the Wave I in-home interview sample, with a few exceptions. Information about neighborhoods/communities was gathered from a variety of previously published databases. Wave III: The in-home Wave III sample consists of Wave I respondents who could be located and re-interviewed six years later. Wave III also collected High School Transcript Release Forms as well as samples of urine and saliva.

Mode of Data Collection:   audio computer-assisted self interview (ACASI), record abstracts, computer-assisted personal interview (CAPI), computer-assisted self interview (CASI), computer-assisted telephone interview (CATI), coded on-site observation, cognitive assessment test, face-to-face interview, paper and pencil interview (PAPI), self-enumerated questionnaire, on-site questionnaire, telephone interview

Extent of Processing:  ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:

  • Performed consistency checks.
  • Standardized missing values.
  • Checked for undocumented or out-of-range codes.

Version(s)

Original ICPSR Release:  

Version History:

  • 2013-11-14 Public release of documentation guides and codebooks.
  • 2013-11-07 Part 4 was added and it includes new Biomarker Lipid Data.
  • 2013-03-08 Part 2 was updated following a resupply of the data by the Principal Investigators. Specifically, additional variables added to the data file, and CRP and EBV values have been recalculated, resulting in minimal changes to the data. The associated documentation and codebook files were also updated. Finally, a user guide describing measures of inflammation and immune function for Part 2 was also added.
  • 2012-11-07 The codebook associated with Part 3, along with a documentation file that contains the original codebook supplied by the principal investigators, was made publicly available.
  • 2012-11-01 Part 3 was added and it includes Biomarker Consent Data. The codebook associated with Part 3, along with a documentation file that contains the original codebook supplied by the principal investigators, was also added. Part 1 was updated, along with the associated documentation files.
  • 2012-05-07 A new CRP and EBV Test restul data has been added to the study as part 2 of the study.
  • 2012-02-28 Documentation was updated.